Read more about Cadila Healthcare Ltd sees sustained buying on Business Standard. Cadila Healthcare Ltd is quoting at Rs 486.2, up 1.46% on the day as on 12:44 IST on the NSE. The stock is up 78.03% in last one year as compared to a 23.2% gain in NIFTY and a 57.09% gain in the Nifty Pharma.
Tata Consumer Products consolidated net profit rose 29% to Rs 237 crore on 23% rise in revenue from operations to Rs 3070 crore in Q3 December 2020 over Q3 December 2019.
Ajanta Pharma s consolidated net profit jumped 64.23% to Rs 176.63 crore on 13.27% rise in total income to Rs 754.22 crore in Q3 December 2020 over Q3 December 2019.
Adani Enterprises informed that the company has incorporated a wholly owned subsidiary namely, Azhiyur Vengalam Road, on 1st February 2021 to carry out the development, maintenance and management of the project in Kerala.
Shares of Home First Finance Company will debut on the bourses today. The issue was sold in the price band of Rs 517-518 apiece.
ASE4PL, a subsidiary of Adani Green Energy, commissioned 100 MW (2x50 MW) Solar Power Plants at Jalalabad in Shahjahanpur district
and Sahaswan in Budaun district of Uttar Pradesh. The plants were commissioned almost 1 month ahead to their scheduled commissioning date.
Both the plants have Power Purchase Agreements (PPAs) with Uttar Pradesh Power Corporation
(UPPCL) at Rs. 3.22/kWh and 3.19/kWh, for a period of 25 years.
With this, the company has added a capacity of 700 MW capacity since the beginning of challenging
COVID-19 pandemic crisis. This places AGEL s total renewable portfolio of 14,815 MW well on
track to reach its vision of 25 GW capacity by 2025.
Read more about Cadila Healthcare rises after USFDA grants orphan drug designation for Saroglitazar Mg on Business Standard. Cadila Healthcare rose 0.69% to Rs 465.40 after the company was granted orphan drug designation by the US drug regulator for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC).